18 Jan Miromatrix
Posted at 19:34h
in
Jeff Ross, Ph.D., CEO
April 13 | 3:30pm | BioCentriq Ballroom
Eden Prairie, MN
(NASDAQ: MIRO)
Miromatrix Medical is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives. The company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The company’s initial development focus is on human livers and kidneys.
